Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2004 5
2005 4
2006 2
2007 3
2008 5
2009 7
2010 9
2011 11
2012 7
2013 9
2014 5
2015 8
2016 8
2017 7
2018 9
2019 4
2020 9
2021 10
2022 6
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
Fenaux P, Platzbecker U, Mufti GJ, Garcia-Manero G, Buckstein R, Santini V, Díez-Campelo M, Finelli C, Cazzola M, Ilhan O, Sekeres MA, Falantes JF, Arrizabalaga B, Salvi F, Giai V, Vyas P, Bowen D, Selleslag D, DeZern AE, Jurcic JG, Germing U, Götze KS, Quesnel B, Beyne-Rauzy O, Cluzeau T, Voso MT, Mazure D, Vellenga E, Greenberg PL, Hellström-Lindberg E, Zeidan AM, Adès L, Verma A, Savona MR, Laadem A, Benzohra A, Zhang J, Rampersad A, Dunshee DR, Linde PG, Sherman ML, Komrokji RS, List AF. Fenaux P, et al. Among authors: beyne rauzy o. N Engl J Med. 2020 Jan 9;382(2):140-151. doi: 10.1056/NEJMoa1908892. N Engl J Med. 2020. PMID: 31914241 Free article. Clinical Trial.
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M; MONALISA study group. Charlier C, et al. Lancet Infect Dis. 2017 May;17(5):510-519. doi: 10.1016/S1473-3099(16)30521-7. Epub 2017 Jan 28. Lancet Infect Dis. 2017. PMID: 28139432 Free article.
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
Fenaux P, Giagounidis A, Selleslag D, Beyne-Rauzy O, Mufti G, Mittelman M, Muus P, Te Boekhorst P, Sanz G, Del Cañizo C, Guerci-Bresler A, Nilsson L, Platzbecker U, Lübbert M, Quesnel B, Cazzola M, Ganser A, Bowen D, Schlegelberger B, Aul C, Knight R, Francis J, Fu T, Hellström-Lindberg E; MDS-004 Lenalidomide del5q Study Group. Fenaux P, et al. Among authors: beyne rauzy o. Blood. 2011 Oct 6;118(14):3765-76. doi: 10.1182/blood-2011-01-330126. Epub 2011 Jul 13. Blood. 2011. PMID: 21753188 Free article. Clinical Trial.
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens.
Sébert M, Freiman L, Chaffaut C, Guerci A, Peterlin P, Thépot S, Beyne-Rauzy O, Park S, Cluzeau T, Chermat F, Fenaux P, Preudhomme C, Clappier E, Chevret S, Adès L, Duployez N, Duchmann M. Sébert M, et al. Among authors: beyne rauzy o. Leukemia. 2024 Apr;38(4):918-922. doi: 10.1038/s41375-024-02180-3. Epub 2024 Feb 17. Leukemia. 2024. PMID: 38368440 No abstract available.
[Management of myelodysplastic syndromes in 2019: An update].
Comont T, Delavigne K, Cougoul P, Bertoli S, Delabesse E, Fenaux P, Beyne-Rauzy O. Comont T, et al. Among authors: beyne rauzy o. Rev Med Interne. 2019 Sep;40(9):581-589. doi: 10.1016/j.revmed.2019.04.001. Epub 2019 May 1. Rev Med Interne. 2019. PMID: 31054780 Review. French.
Immune checkpoint inhibitor-related acral vasculitis.
Comont T, Sibaud V, Mourey L, Cougoul P, Beyne-Rauzy O. Comont T, et al. Among authors: beyne rauzy o. J Immunother Cancer. 2018 Nov 16;6(1):120. doi: 10.1186/s40425-018-0443-6. J Immunother Cancer. 2018. PMID: 30446009 Free PMC article.
Nivolumab-induced eosinophilic fasciitis: a case report.
Ollier N, Tournier E, Meyer N, Sibaud V, Pages-Laurent C, Cougoul P, Beyne-Rauzy O, Comont T. Ollier N, et al. Among authors: beyne rauzy o. Rheumatol Adv Pract. 2020 Jan 28;4(1):rkaa001. doi: 10.1093/rap/rkaa001. eCollection 2020. Rheumatol Adv Pract. 2020. PMID: 32064454 Free PMC article. No abstract available.
[Myelodysplastic syndromes].
Beyne-Rauzy O. Beyne-Rauzy O. Rev Med Interne. 2012 Dec;33 Suppl 2:A21-3. doi: 10.1016/j.revmed.2012.09.015. Epub 2012 Oct 24. Rev Med Interne. 2012. PMID: 23103124 French. No abstract available.
[Anemia of inflammation: Physiopathology and treatment].
Beyne-Rauzy O. Beyne-Rauzy O. Rev Med Interne. 2009 Dec;30 Suppl 4:S311-4. doi: 10.1016/j.revmed.2009.09.013. Epub 2009 Oct 28. Rev Med Interne. 2009. PMID: 19875206 Review. French. No abstract available.
Midostaurin in Advanced Systemic Mastocytosis.
Chandesris MO, Damaj G, Canioni D, Brouzes C, Lhermitte L, Hanssens K, Frenzel L, Cherquaoui Z, Durieu I, Durupt S, Gyan E, Beyne-Rauzy O, Launay D, Faure C, Hamidou M, Besnard S, Diouf M, Schiffmann A, Niault M, Jeandel PY, Ranta D, Gressin R, Chantepie S, Barete S, Dubreuil P, Bourget P, Lortholary O, Hermine O; CEREMAST Study Group. Chandesris MO, et al. Among authors: beyne rauzy o. N Engl J Med. 2016 Jun 30;374(26):2605-7. doi: 10.1056/NEJMc1515403. N Engl J Med. 2016. PMID: 27355555 Clinical Trial. No abstract available.
111 results